Neurological Sciences

, 32:189 | Cite as

A longitudinal evaluation of changes in disability and quality of life in a sample of women with migraine

  • Alberto Raggi
  • Matilde Leonardi
  • Ambra Giovannetti
  • Marcella Curone
  • Gennaro Bussone
  • Domenico D’Amico
Brief Communication

Abstract

Migraine’s high prevalence, which rises up to 25% among women in the productive age, determines a strong reduction in health-related quality of life (HRQoL) and increased disability. Aim of this study is to longitudinally describe disability and HRQoL in a sample of adult women with migraine attending to a specialty centre. HRQoL was measured with the SF-36 and disability with the WHO-DAS II. One-sample t test was used to assess deterioration in disability and HRQoL scales compared to normative scores; effect size was calculated to describe magnitude of change after 3 months. Majority of scales were significantly deteriorated, and changes between baseline and follow-up were negligible to small for most of SF-36 scales, and small to moderate for WHO-DAS II scales. In conclusion, women with migraine showed pervasive deterioration in disability and HRQoL. Wider improvements were observed at follow-up for activities in which relational skills are relevant, while those with a physical component, or that are predominantly performed autonomously, remained almost unchanged.

Keywords Migraine Disability Health-related quality of life WHO-DAS II SF-36 

References

  1. 1.
    Leonardi M, Raggi A, Bussone G, D’Amico D (2010) Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 50:1576–1586PubMedCrossRefGoogle Scholar
  2. 2.
    Raggi A, Leonardi M, Bussone G, D’Amico D (2011) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurol Sci. doi:10.1007/s10072-010-0466-3
  3. 3.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56PubMedCrossRefGoogle Scholar
  4. 4.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054–1062PubMedCrossRefGoogle Scholar
  5. 5.
    Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S59–S62CrossRefGoogle Scholar
  6. 6.
    Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J (2006) Epidemiology of headache in Europe. Eur J Neurol 13:333–345PubMedCrossRefGoogle Scholar
  7. 7.
    Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders. Cephalalgia 24:S1–S160Google Scholar
  8. 8.
    Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036PubMedCrossRefGoogle Scholar
  9. 9.
    Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. Disabil Rehabil 31:553–564PubMedCrossRefGoogle Scholar
  10. 10.
    D’Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, Leone M, Puca FM, Bussone G (2001) The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 21:947–952PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Alberto Raggi
    • 1
  • Matilde Leonardi
    • 1
  • Ambra Giovannetti
    • 1
  • Marcella Curone
    • 2
  • Gennaro Bussone
    • 2
  • Domenico D’Amico
    • 2
  1. 1.Neurology, Public Health and Disability Unit Neurological Institute “C. Besta” IRCCS FoundationMilanItaly
  2. 2.Headaches Center Neurological Institute “C. Besta” IRCCS FoundationMilanItaly

Personalised recommendations